Abstract
using the RSMM. Data from functional parameters such as muscle strength and body composition (DXA) and index of nutritional status has been collected at baseline and after the 2-months intervention. 51 subjects (age: 82,3±6,7 years, BMI 23, 9±5,1 kg/m2, male/female: 17/34; RSMM: 6,28±1,09) were randomized to supplementation received EAAs, 2 times\day) and 43 to placebo (age: 82,8±5,9 years, BMI: 24,8±4,7 kg/m2, male/female: 13/30; RSMM: 6,42±1,27). For last statistical analysis we used two multiple linear regression models. Results.– In account of RSMM (t1) the changes occurred from (and adjusted for) RSMM (t0) (P<0.001) in EAAs group are +0,443 Kg/m2 (P=0,003<0,05). About Lean Mass (LM, t1), the changes occurred in EAAs group, from (and adjusted for) LM (t0) (P<0.001) and Fat Mass (FM, t0), are +1,381 Kg (P=0.001<0.05). Conclusions.– These results indicate that EAAs could play a relevant role in the management of sarcopenia in elderly, favouring in particular the increase of lean mass.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
